Barclays »

Mbx Biosciences shares owned by Barclays

Quarter-by-quarter ownership of Mbx Biosciences shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Mbx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Mbx Biosciences held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mbx Biosciences by Barclays

Quarter filed Position value Share count Share price at filing
2024-09-30 $426k 16k 25.98

More positions owned by Barclays

SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Opt Put Option (QQQ)
Microsoft Corp Opt Call Option (MSFT)
Ishares Tr Opt Call Option (IWM)
Apple Opt Put Option (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Tesla Opt Put Option (TSLA)
Ishares Tr Fund (HYG)
Facebook Inc cl a (META)
Berkshire Hathaway (BRK.B)
Broadcom (AVGO)
Visa (V)
Alphabet Opt Put Option (GOOG)

View all positions for Barclays

Top funds holding Mbx Biosciences

Frazier Life Sciences Management
OrbiMed Advisors
NEA Management Company
NVP Associates
RA Capital Management
T. Rowe Price Associates
Driehaus Capital Management
Woodline Partners
Franklin Resources
Alyeska Investment Group
Platinum Investment Mangement
Citadel Advisors
Stempoint Capital
Monashee Investment Management
TD Asset Management

View all funds holding Mbx Biosciences